Related Experiment Video
Updated: Jun 22, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery
Anshika Sharma1, Gopal K Khuller, Sadhna Sharma
1University of Notre Dame, Department of Biological Sciences, Notre Dame, IN-46556, USA.
Background:
Tuberculosis (TB) remains the most important infectious disease causing morbidity and death, due to the human pathogen Mycobacterium tuberculosis. The emergence of multi-drug-resistant and extensively-drug-resistant forms of TB have resulted in an increase in the number of TB cases. Thus, there is an urgent need to identify new drugs with novel targets to ensure future therapeutic success. Studies have indicated that peptide deformylase is an interesting potential candidate for discovering antimicrobial agents.
Objective:
To explore the role of peptide deformylase, a highly conserved metalloprotease and an essential enzyme in bacterial life cycle, as a target for antibacterial as well as antimycobacterial drug development.
Methods:
This review is based on recent published literature and online resources related to peptide deformylase inhibitors and their antibacterial potential.
Results/Conclusion:
Peptide deformylase is an emerging therapeutic target for the treatment of tuberculosis and peptide deformylase inhibitors can act as potential future antibacterial agents.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
